Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129138 · ClinicalTrials.gov registry record
Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose
A clinical trial of Caregiver and Patient, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 182
- Enrollment target
- 1
- Study location
NCT04129138: Active study of Caregiver and Patient, sponsored by M.D. Anderson Cancer Center.
NCT04129138 is a study of Caregiver and Patient that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 182 participants, below the 1,248-participant average among 20 other Caregiver trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04129138, a study of Caregiver and Patient, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may help to identify barriers to prescribing and helping tailor the education to better meet the needs of patients and caregivers.
Interventions
- OTHER Survey Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2020-07-18 |
| Est. Completion | 2026-06-30 |
What the registry record for NCT04129138 still lists
NCT04129138 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 1,248-participant average among 20 other Caregiver trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Caregiver appearing as the primary indexed condition, and to 1 intervention - of which Survey Administration is the first listed.
NCT04129138 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04129138 about?
NCT04129138 is a clinical study titled "Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose". This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may he...
What is the current status of trial NCT04129138?
This trial is currently active not recruiting. The enrollment target is 182 participants. The study started on 2020-07-18. Estimated completion is 2026-06-30.
What conditions does trial NCT04129138 study?
This clinical trial studies the following conditions: Caregiver, Patient.
What interventions are being tested in trial NCT04129138?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT04129138?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04129138 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04129138's enrollment target sits among peer trials
182 10th of 20 higher than 11 of 20 other Caregiver trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregiver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners
RECRUITING · NA
-
Support for Bereaved Cancer Caregivers
RECRUITING · NA
-
The REACH Intervention for Caregivers of Veterans and Service Members With TBI
RECRUITING · NA
-
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RECRUITING
-
New Assessment System in Measuring Symptom Distress in Cancer Patients
RECRUITING
-
mHealth for Early Psychosis Caregivers in Statewide Program Outreach
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI